AMTG

Open Access
First-in-Human Serum Stability Studies of [¹⁷⁷Lu]Lu-AMTG: A Step Toward Improved GRPR-Targeted Radiopharmaceutical Therapy
Veronika Felber, Nadine Holzleitner, Markus Joksch, Tim Suhrbier, Gunhild von Amsberg, Sarah Schwarzenböck, Jens Kurth, Martin Heuschkel, Thomas Günther and Bernd J. Krause

Journal of Nuclear Medicine June 1, 2025, 66 (6) 896-899; DOI: https://doi.org/10.2967/jnumed.124.269132
You have access
Preclinical Evaluation of Gastrin-Releasing Peptide Receptor Antagonists Labeled with ¹⁶¹Tb and ¹⁷⁷Lu: A Comparative Study
Nadine Holzleitner, Tatjana Cwojdzinski, Roswitha Beck, Nicole Urtz-Urban, Colin C. Hillhouse, Pascal V. Grundler, Nicholas P. van der Meulen, Zeynep Talip, Stijn Ramaekers, Michiel Van de Voorde, Bernard Ponsard, Angela Casini and Thomas Günther

Journal of Nuclear Medicine March 1, 2024, 65 (3) 481-484; DOI: https://doi.org/10.2967/jnumed.123.266233
Open Access
Preclinical Comparison of the ⁶⁴Cu- and ⁶⁸Ga-Labeled GRPR-Targeted Compounds RM2 and AMTG, as Well as First-in-Humans [⁶⁸Ga]Ga-AMTG PET/CT
Lena Koller, Markus Joksch, Sarah Schwarzenböck, Jens Kurth, Martin Heuschkel, Nadine Holzleitner, Roswitha Beck, Gunhild von Amsberg, Hans-Jürgen Wester, Bernd Joachim Krause and Thomas Günther

Journal of Nuclear Medicine October 1, 2023, 64 (10) 1654-1659; DOI: https://doi.org/10.2967/jnumed.123.265771
Open Access
Substitution of l-Tryptophan by α-Methyl-l-Tryptophan in ¹⁷⁷Lu-RM2 Results in ¹⁷⁷Lu-AMTG, a High-Affinity Gastrin-Releasing Peptide Receptor Ligand with Improved In Vivo Stability
Thomas Günther, Sandra Deiser, Veronika Felber, Roswitha Beck and Hans-Jürgen Wester

Journal of Nuclear Medicine September 1, 2022, 63 (9) 1364-1370; DOI: https://doi.org/10.2967/jnumed.121.263323

Main menu

User menu

Search

AMTG